Literature DB >> 28106481

MiR-320a effectively suppresses lung adenocarcinoma cell proliferation and metastasis by regulating STAT3 signals.

Qing Lv1, Jin-Xia Hu1, You-Jie Li1, Ning Xie2, Dan Dan Song1, Wei Zhao1, Yun-Fei Yan1, Bao-Sheng Li3, Ping-Yu Wang1, Shu-Yang Xie1.   

Abstract

MicroRNAs play important roles in tumorigenesis of various types of cancers. MiR-320a can inhibits cell proliferation of some cancers, but the biologic roles of miR-320a in lung cancer need to be further studied. Here, we investigated the roles of miR-320a in suppressing the proliferation of lung adenocarcinoma cells. MiR-320a treatment was found to effectively suppress LTEP-a-2 and A549 cell proliferation, and induce more apoptotic cells with irradiation treatment compared with control treatment. Our results also showed that miR-320a, as a novel miRNA, directly regulated signal transducer and activator of transcription 3 (STAT3) and its signals, such as Bcl-2, Bax, and Caspase 3. The siRNA-inhibited STAT3 levels further proved its roles in regulating STAT3 signals. Moreover, miR-320a treatment effectively suppressed cancer cell growth in mice xenografts compared with controls, and significantly inhibited cell migration in vitro and in vivo. Our findings collectively demonstrated that miR-320a, by directly regulating STAT3 signals, not only suppressed cell proliferation and metastasis, but also enhanced irradiation-induced apoptosis of adenocarcinomia cells.

Entities:  

Keywords:  Cell proliferation; NSCLC; STAT3; metastasis; miR-320a

Mesh:

Substances:

Year:  2017        PMID: 28106481      PMCID: PMC5389432          DOI: 10.1080/15384047.2017.1281497

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  33 in total

1.  Radiation induces phosphorylation of STAT3 in a dose- and time-dependent manner.

Authors:  Ling Gao; Feng-Sheng Li; Xiao-Hua Chen; Qiao-Wei Liu; Jiang-Bin Feng; Qing-Jie Liu; Xu Su
Journal:  Asian Pac J Cancer Prev       Date:  2014

2.  Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.

Authors:  Jian-Huang Li; Ning Luo; Mei-Zuo Zhong; Zhi-Qiang Xiao; Jian-Xin Wang; Xiao-Yi Yao; Yun Peng; Jun Cao
Journal:  Tumour Biol       Date:  2015-09-16

3.  Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors.

Authors:  Ping-Yu Wang; Yun-Xiao Sun; Shuai Zhang; Min Pang; Han-Han Zhang; Shu-Yan Gao; Can Zhang; Chang-Jun Lv; Shu-Yang Xie
Journal:  FEBS Lett       Date:  2013-07-11       Impact factor: 4.124

4.  Determination of plasma microRNA for early detection of gastric cancer.

Authors:  Aysegul Gorur; Senay Balci Fidanci; Nil Dogruer Unal; Lokman Ayaz; Serin Akbayir; Hatice Yildirim Yaroglu; Musa Dirlik; Mehmet Sami Serin; Lulufer Tamer
Journal:  Mol Biol Rep       Date:  2012-12-01       Impact factor: 2.316

5.  MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells.

Authors:  Ji Hyun Chang; Yeo Hyun Hwang; David J Lee; Dan Hyo Kim; Ji Min Park; Hong-Gyun Wu; In Ah Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-09       Impact factor: 7.038

6.  Radiation-induced microRNA-622 causes radioresistance in colorectal cancer cells by down-regulating Rb.

Authors:  Wenhui Ma; Jiang Yu; Xiaolong Qi; Li Liang; Yan Zhang; Yi Ding; Xiaoshan Lin; Guoxin Li; Yanqing Ding
Journal:  Oncotarget       Date:  2015-06-30

Review 7.  MicroRNA dysregulation in uveal melanoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Jiang
Journal:  Oncotarget       Date:  2015-03-10

8.  MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.

Authors:  Jia-Quan Qu; Hong-Mei Yi; Xu Ye; Li-Na Li; Jin-Feng Zhu; Ta Xiao; Li Yuan; Jiao-Yang Li; Yuan-Yuan Wang; Juan Feng; Qiu-Yan He; Shan-Shan Lu; Hong Yi; Zhi-Qiang Xiao
Journal:  Oncotarget       Date:  2015-09-29

9.  Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.

Authors:  Rajesh Mukthavaram; Xiao Ouyang; Rohit Saklecha; Pengfei Jiang; Natsuko Nomura; Sandeep C Pingle; Fang Guo; Milan Makale; Santosh Kesari
Journal:  J Transl Med       Date:  2015-08-18       Impact factor: 5.531

10.  MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.

Authors:  Radhakrishnan Vishnubalaji; Rimi Hamam; Shijun Yue; Omar Al-Obeed; Moustapha Kassem; Fei-Fei Liu; Abdullah Aldahmash; Nehad M Alajez
Journal:  Oncotarget       Date:  2016-06-14
View more
  28 in total

1.  The long non-coding RNA SUMO1P3 facilitates breast cancer progression by negatively regulating miR-320a.

Authors:  Jie Liu; Zhiwang Song; Chan Feng; Yonglin Lu; Yu Zhou; Yun Lin; Chunyan Dong
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.

Authors:  Jie Shen; Wei Zhou; Nan Bi; Yong-Mei Song; Fu-Quan Zhang; Qi-Min Zhan; Lv-Hua Wang
Journal:  Cancer Biol Ther       Date:  2018-09-19       Impact factor: 4.742

Review 3.  MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

4.  Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession.

Authors:  Yuan-Rong Liu; Dan-Dan Song; Dong-Min Liang; You-Jie Li; Yun-Fei Yan; Hong-Fang Sun; Mei-Ling Zhang; Jin-Xia Hu; Yu-Long Zhao; Yan Liang; Yan-Mei Li; Zhen Yang; Ran-Ran Wang; Hou-Feng Zheng; Pingyu Wang; Shu-Yang Xie
Journal:  Cell Death Discov       Date:  2022-07-05

5.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

6.  MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.

Authors:  E Krasniqi; A Sacconi; G Blandino; P Vici; D Marinelli; L Pizzuti; M Mazzotta; D Sergi; E Capomolla; S Donzelli; M Carosi; A Bagnato; T Gamucci; S Tomao; C Natoli; P Marchetti; A Grassadonia; N Tinari; M De Tursi; E Vizza; G Ciliberto; L Landi; F Cappuzzo; M Barba
Journal:  Biomark Res       Date:  2021-07-13

7.  Small non-coding RNA profiling in human biofluids and surrogate tissues from healthy individuals: description of the diverse and most represented species.

Authors:  Giulio Ferrero; Francesca Cordero; Sonia Tarallo; Maddalena Arigoni; Federica Riccardo; Gaetano Gallo; Guglielmo Ronco; Marco Allasia; Neha Kulkarni; Giuseppe Matullo; Paolo Vineis; Raffaele A Calogero; Barbara Pardini; Alessio Naccarati
Journal:  Oncotarget       Date:  2017-12-14

Review 8.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

Review 9.  MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Authors:  Yuanyuan Liang; Shun Li; Liling Tang
Journal:  Biomedicines       Date:  2021-05-23

10.  p100 functions as a metastasis activator and is targeted by tumor suppressing microRNA-320a in lung cancer.

Authors:  Aimin Xing; Li Pan; Jingzhen Gao
Journal:  Thorac Cancer       Date:  2017-11-21       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.